Ipca Laboratories Ltd.

IPCALAB

₹1537.75

0.89% (13.55)

Market Cap

₹38,670 Cr.

P/E

58.48

About

Established in 1949, IPCA Laboratories Limited is an integrated pharmaceutical company that manufactures and markets various formulations and APIs for different therapeutic segments. With a global pre… Read more

Established in 1949, IPCA Laboratories Limited is an integrated pharmaceutical company that ma… Read more

Low

1042

52W Range

High

1709

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

9 Yes

Positive for this company

3 Neutral

Neutral for this company

5 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Depreciation Effect

Depreciation accounting is not leading to increase in profits
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Retail Holding

Retail has been selling the stock which is usually a good time to buy
Promoter Holding

Promoter has not sold any shares in the last 90 days
Revenue Recognition

Chances of aggressive revenue recognition - operating profit of company is not getting converted to cash and recievables rising faster than sales

Price & Performance

ROE

Asset turnover is responsible for roe increase over last 10 years
Share price

Share price has increased over last 10 years due to earnings
Debt

Company should not have issues servicing its debt
Sales Growth

Sales of the company has grown at a good pace
Capex vs ROCE

Company has made significant capex which might be affecting its roce
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Current vs Historic Valuation

Company is trading at a premium to 3yr historic valuations
Working Capital

Company has significant working capital which is dragging its roce and roe
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong

Market Share

0.81 %

(as of Jul 22)

Historic

Anti - Diabetes - Market Share

1.03 %

(as of Jul 22)

Historic

Anti-Infectives - Market Share

55.08 %

(as of Nov 21)

Historic

Anti-Malarial - Market Share

3.84 %

(as of Nov 21)

Historic

Antineo Plastic - Market Share

0.11 %

(as of Nov 21)

Historic

Blood Related - Market Share

2.09 %

(as of Jul 22)

Historic

Cardiovascular - Market Share

1.20 %

(as of Nov 21)

Historic

Dermatology - Market Share

0.12 %

(as of Nov 21)

Historic

Endocrinology - Market Share

1.02 %

(as of Jul 22)

Historic

Gastro-Intestinal - Market Share

1.11 %

(as of Nov 21)

Historic

Neurological - Market Share

0.55 %

(as of Nov 21)

Historic

Ophthalmology - Market Share

8.06 %

(as of Nov 21)

Historic

Pain - Market Share

1.80 %

(as of Dec 22)

Historic

Pharmaceutical Sector - Market Share

0.83 %

(as of Nov 21)

Historic

Respiratory - Market Share

0.39 %

(as of Jul 22)

Historic

Sex Stimulants - Market Share

2.23 %

(as of Nov 21)

Historic

Urology - Market Share

0.43 %

(as of Jul 22)

Historic

Vitamin & Dietary Supplements - Market Share

Revenue mix

Product Wise Break-Up

Therapeutic Area Wise Break-Up - Domestic

Location Wise Break-Up - Branded Generics

Location Wise Break-Up - Generics

Location Wise Break-Up - API

Location Wise Break-Up

Therapeutic Area Break-Up

Operational Metrics

US DMF Filings (.)
Source
Number of ANDA's Filed in USA (.)
Source
Number of ANDA's Approved By USFDA (.)
Source
Domestic Sales Growth - YoY (%)
Source
R&D as a % of Total Sales (%)
Source

Peer Comparison

Suppliers

Bharat Dynamics Ltd.
Elgi Equipments Ltd.
Borosil Renewables Ltd.
GMM Pfaudler Ltd.
Gulshan Polyols Ltd.
Iris Business Services Ltd.
TPL Plastech Ltd.
Take Solutions Ltd.

Showing 5 of 8

FAQs on Ipca Laboratories Ltd. Business

What does Ipca Laboratories do?

IPCA Laboratories Limited is a pharmaceutical company founded in 1949, with a global presence in manufacturing and marketing various formulations and APIs across different therapeutic segments. It is a leading supplier of APIs worldwide.

Who are the competitors of Ipca Laboratories?

Ipca Laboratories major competitors are Ajanta Pharma, Glaxosmithkline Phar, Glenmark Pharma, Gland Pharma, JB Chem & Pharma, Natco Pharma, Pfizer.
Market Cap of Ipca Laboratories is ₹38,848 Crs.
While the median market cap of its peers are ₹29,281 Crs.

Is Ipca Laboratories financially stable compared to its competitors?

Ipca Laboratories seems to be less financially stable compared to its competitors.
Altman Z score of Ipca Laboratories is 6.94 and is ranked 7 out of its 8 competitors.

View FAQ's On Shareprice

Monopoly Companies

Companies which are dominant in a product, usually having a strong moat.

Run Query

Company Filing

	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Investor Presentation	Dec Mar Jun Sep	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Conference Call	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Conference Call SummaryCon Call Summary Powered by OpenAI	Dec			Mar Jun	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec